Atossa Therapeutics, Inc. beat EPS estimates 100% of the time across 2 reported quarters (2 beats, 0 misses). Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result |
|---|---|---|---|---|
| Q22026 FY2026 | $-1.04 | — | — | Miss |
| Q22026 FY2026 | $-1.04 | $-0.95 | +8.7% | Beat |
| Q12026 FY2026 | $-1.22 | $-1.11 | +9.0% | Beat |
Back to ATOS overview · ATOS holders · ATOS KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.